Funding

Every year we help thousands of people with psoriasis and psoriatic arthritis via our websites, helpline, publications and through our research programme.

We rely on the generosity of people like you to help us continue our vital work. From becoming a member through to fundraising, regular giving through to leaving a legacy, there are lots of ways that you can donate.

With no funding from Government or the Department of Health, we really do depend on your support to help us achieve our aims.

For more information on the Funding and Expenditure of the Psoriasis Association, please download our annual Our Achievements report:

Our Achievements 2023   Audited Accounts 2023

Our Achievements 2022       Audited Accounts 2022

Our Achievements 2021       Audited Accounts 2021

Our Achievements 2020        

Our Achievements 2019          

The Psoriasis Association receives funding from the following pharmaceutical companies to support some of its activities and projects (AbbVie, Almirall, Bristol Myers Squibb (BMS), Dermal Laboratories Ltd, Johnson & Johnson Innovative Medicine, Medac Pharma, Novartis, T&R Derma and UCB.

These pharmaceutical companies have no influence over the conduct or content of any of the Psoriasis Association’s activities and projects.